Cochrane Abstracts
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Thrombin Inhibitors Versus Vitamin K Antagonists or Low Molecular Weight Heparins for Prevention of Venous Thromboembolism Following Total Hip or Knee Replacement: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review.
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review. Accessed December 7, 2024.
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review
Direct Thrombin Inhibitors Versus Vitamin K Antagonists or Low Molecular Weight Heparins for Prevention of Venous Thromboembolism Following Total Hip or Knee Replacement: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
ID - 439783
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
